Huantai Biotechnology Co., Ltd.

Huantai Biotechnology Co., Ltd. operates in 29 countries across 13 regions, with Western Europe representing 21% (6 countries) and Middle East at 14% (4 countries). North America, Oceania, and Southeast Asia each account for 10% (3 countries each), while East Asia, North Africa, and several smaller regions hold 3% each. This distribution shows a balanced but regionalized footprint, with significant presence in Europe and the Middle East, contrasting with typical suppliers who often focus on 5–10 markets in a single region. The spread across diverse geographies suggests a strategy aimed at global compliance and market access, though limited concentration in high-growth areas may affect scalability.